Clinical trials
Completed Observational trials in Tanzania
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 7 |
| 2019 | 7 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 4 |
| Cornell University | 2 |
| Elizabeth Glaser Pediatric AIDS Foundation | 2 |
| International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2 |
| Karolinska University Hospital | 2 |
| Michael Hoelscher | 2 |
| Muhimbili University of Health and Allied Sciences | 2 |
| National Institute for Medical Research, Tanzania | 2 |
| Swiss Federal Institute of Technology | 2 |
| Swiss Tropical & Public Health Institute | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 8 |
| Acquired Immunodeficiency Syndrome | 5 |
| Fever | 5 |
| Malaria | 4 |
| Tuberculosis | 4 |
| Diabetes Mellitus | 3 |
| Disease | 3 |
| Malnutrition | 3 |
| COVID-19 | 2 |
| Communicable Diseases | 2 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.